CliffBio
small molecule

CEFDINIR

CEFDINIR

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameCEFDINIR
Active ingredientCEFDINIR
Strength250MG/5ML
Dosage formFOR SUSPENSION
RouteORAL
ModalitySmall molecule
FDA approvalMay 2007
Marketing statusRX

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.